Sargent Investment Group LLC bought a new stake in shares of Viveve Medical Inc (NASDAQ:VIVE) in the 4th quarter, HoldingsChannel.com reports. The firm bought 30,000 shares of the company’s stock, valued at approximately $32,000.
Separately, Bank of New York Mellon Corp raised its position in Viveve Medical by 266.6% in the 4th quarter. Bank of New York Mellon Corp now owns 45,223 shares of the company’s stock valued at $47,000 after purchasing an additional 32,888 shares during the last quarter. 56.54% of the stock is currently owned by institutional investors.
Get Viveve Medical alerts:Several brokerages have issued reports on VIVE. ValuEngine downgraded Viveve Medical from a “buy” rating to a “hold” rating in a research report on Saturday, November 10th. Raymond James cut their price objective on Viveve Medical from $4.50 to $3.00 and set an “outperform” rating for the company in a research report on Wednesday, December 12th. Craig Hallum set a $1.00 price objective on Viveve Medical and gave the company a “hold” rating in a research report on Friday, January 18th. Finally, Maxim Group reiterated a “buy” rating on shares of Viveve Medical in a research report on Thursday, January 17th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Viveve Medical presently has a consensus rating of “Buy” and an average price target of $5.20.
Shares of VIVE stock traded up $0.05 on Tuesday, reaching $1.03. 250 shares of the stock were exchanged, compared to its average volume of 132,244. The company has a market cap of $32.80 million, a P/E ratio of -0.48 and a beta of 0.80. Viveve Medical Inc has a one year low of $0.93 and a one year high of $4.40. The company has a quick ratio of 3.20, a current ratio of 3.72 and a debt-to-equity ratio of 3.42.
WARNING: “Sargent Investment Group LLC Buys Shares of 30,000 Viveve Medical Inc (VIVE)” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another domain, it was stolen and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.tickerreport.com/banking-finance/4198817/sargent-investment-group-llc-buys-shares-of-30000-viveve-medical-inc-vive.html.Viveve Medical Profile
Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable accessories.
Featured Story: Percentage Decliners
Want to see what other hedge funds are holding VIVE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viveve Medical Inc (NASDAQ:VIVE).
No comments:
Post a Comment